- Home
- INKT vs BRLT Comparison
INKT vs BRLT Comparison
Compare INKT & BRLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- BRLT
- Stock Information
- Founded
- INKT 2017
- BRLT 2005
- Country
- INKT United States
- BRLT United States
- Employees
- INKT N/A
- BRLT N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- BRLT Consumer Specialties
- Sector
- INKT Health Care
- BRLT Consumer Discretionary
- Exchange
- INKT Nasdaq
- BRLT Nasdaq
- Market Cap
- INKT 36.7M
- BRLT 22.6M
- IPO Year
- INKT 2021
- BRLT 2021
- Fundamental
- Price
- INKT $8.18
- BRLT $1.54
- Analyst Decision
- INKT Strong Buy
- BRLT Hold
- Analyst Count
- INKT 2
- BRLT 5
- Target Price
- INKT $19.50
- BRLT $2.40
- AVG Volume (30 Days)
- INKT 11.3K
- BRLT 82.9K
- Earning Date
- INKT 03-18-2025
- BRLT 03-12-2025
- Dividend Yield
- INKT N/A
- BRLT N/A
- EPS Growth
- INKT N/A
- BRLT N/A
- EPS
- INKT N/A
- BRLT 0.03
- Revenue
- INKT N/A
- BRLT $426,982,000.00
- Revenue This Year
- INKT N/A
- BRLT N/A
- Revenue Next Year
- INKT N/A
- BRLT $1.04
- P/E Ratio
- INKT N/A
- BRLT $50.23
- Revenue Growth
- INKT N/A
- BRLT N/A
- 52 Week Low
- INKT $4.56
- BRLT $1.25
- 52 Week High
- INKT $19.00
- BRLT $3.21
- Technical
- Relative Strength Index (RSI)
- INKT 42.71
- BRLT 38.86
- Support Level
- INKT $7.90
- BRLT $1.26
- Resistance Level
- INKT $8.43
- BRLT $1.42
- Average True Range (ATR)
- INKT 0.81
- BRLT 0.10
- MACD
- INKT -0.19
- BRLT 0.01
- Stochastic Oscillator
- INKT 8.07
- BRLT 38.64
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
About BRLT Brilliant Earth Group Inc.
Brilliant Earth Group Inc designs, procures and sells ethically-sourced diamonds, gemstones and jewelry online and through showrooms. Its sales consist of revenue from diamond, gemstone, and jewelry retail sales. The company sells its products in the U.S. and other international countries, of which a majority of revenue is derived from the U.S.